Trulicity

Dulaglutide (trade name: Trulicity) has been approved in Germany since November 2014 for the treatment of type 2 diabetes when diet and exercise alone do not reduce blood sugar levels enough. Dulaglutide can be used alone or in combination with other blood-sugar-lowering drugs if they do not control blood sugar levels well enough on their own. Diabetes is a metabolic disease that affects many parts of the body. In type 2 diabetes, the pancreas still produces enough insulin at first, but the body’s cells gradually lose the ability to absorb and use the insulin. If blood sugar levels can’t be lowered enough by changes in diet and exercise, blood-sugar-lowering drugs are used. Treatment with dulaglutide aims to avoid strong fluctuations in blood sugar levels and prevent problems caused by high and low blood sugar. It also aims to prevent as much as possible long-term complications that can result from blood sugar levels being too high.